NASH prevalence is on the rise, but research focusing on the central role of liver health may be important for understanding this disease1

Ongoing research centers on the rising prevalence of NASH with fibrosis and need for effective management options1,2

Stay informed as the NASH conversation evolves.

Sign up to receive emails for new information on NASH with fibrosis.

All fields are required.

By clicking “Subscribe” you certify that you are 18 years of age or older.

By providing your information, you consent to receive corporate communications and other information from Madrigal Pharmaceuticals, including information on NASH and how it may be treated. You hereby give consent to Madrigal, its affiliates, and their agents and representatives to send communications and information to you via the contact information you have provided above. This consent will be in effect until such a time as you opt out of communications from Madrigal.